| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 333,551 | 350,969 | 374,237 | 355,525 | | Cost of Revenue | 228,961 | 266,521 | 228,713 | 257,199 | | | Gross Profit | 104,590 | 84,448 | 145,524 | 98,326 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 36,785 | 9,667 | 71,580 | 43,647 | | Non Recurring | 2,360 | (10,453) | (31,491) | 171,130 | | Others | 3,019 | 3,018 | 3,019 | 3,076 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 62,426 | 82,216 | 102,416 | (119,527) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 11,171 | | Earnings Before Interest And Taxes | 62,426 | 82,216 | 102,416 | (108,356) | | Interest Expense | 45,231 | 45,848 | 48,532 | 50,443 | | Income Before Tax | 17,195 | 36,368 | 53,884 | (158,799) | | Income Tax Expense | 3,690 | 11,554 | 16,743 | (21,380) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,505 | 24,814 | 37,141 | (137,419) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 295 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,505 | 24,814 | 37,141 | (137,124) | | Preferred Stock And Other Adjustments | (5,622) | (6,032) | (6,513) | (78) | | | Net Income Applicable To Common Shares | $7,883 | $18,782 | $30,628 | ($137,202) |
|
1.12% Nasdaq 
Income Statement
